Pricing

Log inSign up

Kymera Therapeutics

171 people · 6 jobs
‌

Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.

Industries

Biotechnology

Headquarters

Watertown, United States

Employees

51-200

Links

Org chart

Hiring!

Nello Mainolfi
Co-Founder, President & CEO
Collapse
Jared Gollob
Chief Medical Officer
Bruce Jacobs
CFO
Jeremy Chadwick
COO
Karen Weisbach
VP, People & Culture
Aimee Mishkin
VP, Regulatory Affairs
Hiring
Associate Director, Clinical Pharmacology
Vacant position
Noah Goodman
Chief Business Officer
Mike Legato
Senior Director, IT Applications
Matt Foroughi
Senior Manager, Cybersecurity
Matthew Weiss
Vp, Head Of Chemistry And Early Drug Discovery
Lea Florentino
Executive Business Partner To The CEO
Randy Barnes
Executive Director, CMC Technical Operations
Keith Fleischer
Director, Contracts Counsel

Board & advisors

Bruce Booth
Co-Founder & Chairman
Jeff Albers
Director
Pamela L. Esposito
Director
Joanna Horobin
Director
Gorjan Hrustanovic
Director
Elena Ridloff
Director
Leigh Morgan
Director
John Maraganore
Director
SC
Steven A. Carr
Scientific Advisor
JC
Jean-Laurent Casanova
Scientific Advisor
DF
David Frank
Scientific Advisor
NK
Nick Keen
Scientific Advisor
AS
Antonio Sica
Scientific Advisor
DS
David Spiegel
Scientific Advisor
RT
Robert Terkeltaub
Scientific Advisor

Similar companies

Sutro Biopharma

3 followers

Active Motif

3 followers

Dyno Therapeutics

4 followers

Janux Therapeutics

1 follower

Eikon Therapeutics

3 followers

Gilead Sciences

169 followers

Regeneron

141 followers

Illumina

80 followers

Agilent Technologies

88 followers

Verily Life Sciences

47 followers

Alexion Pharmaceuticals

48 followers

Explore companies